| Similar Articles |
|---|
 |
Chemistry World
August 23, 2013
Jessica Cocker |
Plant protein regulates diabetes treatment A plant protein has been used to make a new class of glucose-responsive polymer nanogels that could one day negate the need for diabetes patients to constantly monitor their blood glucose levels and inject themselves with insulin.   |
Salon.com
January 22, 2001
Janet Lafler |
I'm a cyborg and I love it My portable insulin pump never strays from my side, but I feel more human with the technology than without it... |
The Motley Fool
July 17, 2006
Stephen D. Simpson |
Medtronic's Evolutionary Revolution Step by step, Medtronic may change how diabetes is treated. |
Nurse Practitioner
May 2011
Stacey A. Seggelke |
Hitting the target for inpatient glycemic management An understanding of glycemic treatment options for hospitalized patients is essential for good patient outcomes. |
Nursing
November 2009
Christine Kessler |
Glycemic control in the hospital: How tight should it be? Based on recent studies, the answer to that question remains controversial. This article will explore this issue and present current best practices for caring for a patient in the hospital who has diabetes or hyperglycemia. |
IEEE Spectrum
October 2011
Joseph M. Smith |
Wireless Health Care Wireless technologies are about to transform health care, and not a moment too soon |
IEEE Spectrum
January 2011
Sandra Upson |
Bionic Pancreas Artificial organ could improve control over diabetes |
American Family Physician
May 1, 2005 |
Diabetic Ketoacidosis: What It Is and How to Prevent It An informative patient hand-out on the condition, its causes, triggers, prevention and instructions on what do if the conditions presents. |
The Motley Fool
June 27, 2005
Stephen D. Simpson |
Sniffing Out a Possible Diabetes Blockbuster Inhaled insulin has been a Holy Grail of diabetes care. Will it live up to lofty expectations? Pfizer, Sanofi-Aventis, and Lilly are all interesting in their own right as high-quality pharmaceutical companies, and more aggressive investors should take a look at Nektar and Alkermes, as well. |
American Family Physician
September 15, 2006
Havas & Donner |
Tight Control of Type 1 Diabetes: Recommendations for Patients Physicians play an important role in helping type 1 diabetes patients make essential lifestyle changes to help reduce the risk of microvascular and macrovascular complications. |
Nursing Management
January 2012
Lawrence et al. |
Type 2 Diabetes: Growing to Epic Proportions Affecting all age groups and all aspects of a person's life, diabetes is a major public health issue worldwide, requiring lifelong behavioral and lifestyle changes and support. |
BusinessWeek
February 28, 2005
Gene G. Marcial |
J&J May Pump Up Animas Animas, a little-known maker of small glucose pumps, could take a big share of the insulin-measurement market. |
Managed Care
March 2004
Thomas Morrow |
Insulin Pumps Buy Time Until Transplant Therapy Arrives Improvements in the features of diabetes pumps have evolved since their original backpack-size days. Managed care needs to evaluate the new bells and whistles. |
The Motley Fool
May 20, 2009
Brian Orelli |
Joining to Treat, and Beat, Diabetes Medical-device maker Medtronic and drugmaker Eli Lilly are teaming up to co-promote the companies' diabetes products to doctors and patients. |
Nurse Practitioner
October 2010
Hill & Appel |
Diagnosing Diabetes with A1C: Implications and Considerations for Measurement and Surrogate Markers Now that the ADA has officially positioned the assay as a means of diagnosis and monitoring, it is another tool NPs must access properly when helping patients manage diabetes and treatment. |
American Family Physician
November 1, 2000 |
Diabetes: Flexible Insulin Regimens for People with Type 1 Diabetes What is insulin?... How do I use insulin?... What is a flexible insulin regimen?... When should I take insulin?... |
American Family Physician
January 1, 2003
Jennifer B. Marks |
Perioperative Management of Diabetes Diabetic patients who require surgery present special challenges in perioperative management. Special attention must be paid to prevention and treatment of metabolic derangements. |
AskMen.com
April 29, 2001
Joshua Levine |
Do You Have Diabetes? Diabetes is not contagious; people cannot "catch" it from one another. However, certain factors can increase one's risk of developing the disease... |
BusinessWeek
April 8, 2010
Arlene Weintraub |
Diabetes Is No Fun, but It Can Be a Game Bayer hopes that partnering with Nintendo will make it the leader in glucose testing. |
American Family Physician
August 1, 2004
Mayfield & White |
Insulin Therapy for Type 2 Diabetes: Rescue, Augmentation, and Replacement of Beta-Cell Function New insulin preparations and a better understanding of insulin physiology provide more options for family physicians attempting to effectively tailor insulin therapy to the needs of individual patients. |
American Family Physician
May 1, 2001 |
Treatment Options for Type 2 Diabetes -- What's Available? What are the different steps in managing my diabetes? What are the different types of medicines used to treat type 2 diabetes and how do they work? |
BusinessWeek
April 30, 2010
Drew Armstrong |
The Lobbying for Death by Diabetes How a health-reform provision may help spur sales of insulin. |
The Motley Fool
October 2, 2009
Brian Orelli |
Warning! Potential Blockbuster Ahead It's a little early to call it, but it looks like Bristol-Myers Squibb and AstraZeneca have a potential blockbuster on their hands with their new diabetes drug. |
AskMen.com
Alex Santoso |
What You Should Know About Diabetes Not many men understand what diabetes is, why it's very bad for them (it is one of the leading causes of impotence), what they can do to avoid getting it or how to treat it. |
Chemistry World
April 8, 2014
Sarah Kenwright |
Olive oil may offer diabetes protection Spanish scientists say increasing the amount of olive oil in your diet could reduce your risk of developing metabolic syndrome and type 2 diabetes. |
The Motley Fool
June 23, 2010
Brian Orelli |
Duo of Diabetes Drug Deals Make J&J Better Licensing deals add to Johnson & Johnson's diabetes franchise. |
Food Processing
August 2013
Mark Anthony |
The Condemnation of Carbohydrates: A Food Manufacturers Guide to Understanding Diabetes The commonly held notion that sugar intake equals diabetes is a kind of unofficial dogma. But like many dogmas, this one falls apart upon closer examination. |
The Motley Fool
October 2, 2007
Brian Orelli |
Amylin's Bittersweet FDA News Diabetes drug moves ahead, but not as much as the company wanted. If the FDA rejection was due to safety issues, that wouldn't bode well for Amylin's plans to develop the active ingredient in SYMLIN as a weight-loss drug. Investors, take note. |
Pharmaceutical Executive
November 1, 2008
George Koroneos |
Tech Toys Here are the hottest gadgets and gizmos to make a dent in drug noncompliance. |
Chemistry World
June 22, 2015
Manisha Lalloo |
'Smart patch' set to deliver for diabetes patients A research team has created patches that release insulin in response to changes in oxygen brought about by high glucose levels and hope this could lead to a smarter, painless way of treating the disease. |
The Motley Fool
October 27, 2005
Stephen D. Simpson |
What's New With Novo? Novo Nordisk is a good play on diabetes, but will new drugs reduce the need for insulin? Investors, take note. |
American Family Physician
March 15, 2001
Goutham Rao |
Insulin Resistance Syndrome Insulin resistance can be linked to diabetes, hypertension, dyslipidemia, cardiovascular disease and other abnormalities. Because resistance usually develops long before these diseases appear, identifying and treating insulin-resistant patients has potentially great preventive value... |
American Family Physician
July 15, 2006
Jennifer D. Goldman-Levine |
Insulin Detemir (Levemir) for Diabetes Mellitus Insulin detemir is suitable as basal insulin in a basal-bolus regimen. In limited research, it has been shown to cause slightly fewer episodes of minor hypoglycemia and no weight gain in patients with type 1 and 2 diabetes, which is a benefit that must be balanced against its higher price. |
American Family Physician
May 1, 2005
David E. Trachtenbarg |
Diabetic Ketoacidosis Initial evaluation of patients with DKA includes diagnosis and treatment of precipitating factors. Education to prevent recurrence should be offered to all patients, including how to manage sick days and when to call a physician. |
The Motley Fool
June 28, 2010
Luke Timmerman |
Orexigen Drug Shows Potential as "Two-Fer" Against Obesity and Diabetes Orexigen's latest drug aims at treating both diabetes and obesity. |
The Motley Fool
September 30, 2011
Brian Orelli |
A Drug Market That's 366 Million Strong Diabetes drugs have potential. |
The Motley Fool
May 10, 2011
Brian Orelli |
Waiting for MannKind's Pot of Gold It's going to be awhile. |
Chemistry World
November 9, 2010
Andrew Turley |
Company snapshot: Novo Nordisk As the results for the third quarter of this year roll in, one pharma major - Danish company Novo Nordisk - seems to have done better than most with its diabetes medicines. |
Pharmaceutical Executive
October 1, 2005 |
Changing Diabetes An interview with Novo Nordisk's president of U.S. operations Martin Soeters on how a nation that leads the world in diabetes research does such a poor job of treating it. Here, he offers some solutions. |
BusinessWeek
October 22, 2009
Arlene Weintraub |
Tough Love, Lower Health Costs A UnitedHealthcare plan offers incentives to employees who strictly control their diabetes. |
The Motley Fool
July 27, 2007
Rich Duprey |
Sniffing Out Bentley's New Patent To succeed in insulin therapy, the generic drugmaker must overcome patent expiration. Investors, take note. |
Pharmaceutical Executive
November 1, 2014
William Looney |
Dane in America Jesper Hoiland, Novo Nordisk's President for North America, assesses the challenges and opportunities during his first year at the helm of the diabetes franchise leader's biggest affiliate market. |
Chemistry World
June 26, 2013
Emma Stoye |
Glucose-sensing contact lens could run on power of tears Diabetics could one day be able to monitor their blood sugar levels using bionic contact lenses. Researchers have developed a fuel cell that runs on tears, which they say could power lens-mounted glucose sensors. |
The Motley Fool
June 19, 2009
Robert Steyer |
MannKind Needs More Leaps Getting FDA approval for its inhaled-insulin product is only one hurdle for this start-up pharmaceutical. |
Scientific American
December 12, 2005
Philip E. Ross |
Grow Your Own Getting a diabetic pancreas to regrow its islets -- growth factors could restore beta cells lost in type 1 diabetes. |
Managed Care
July 2004
Udaya M. Kabadi |
Cost-Effective Management of Hyperglycemia in Patients with Type 2 Diabetes Using Oral Agents Sulfonylureas are cost-effective and also may be the only oral agents that inhibit processes inducing hyperglycemia by improving insulin secretion and insulin resistance. New long-acting agents hold even greater promise. |
Managed Care
May 2007
Rachel M. Renshaw |
Keys to Diabetes Control? Patience, Persistence, and Perseverance Careful attention to a comprehensive treatment plan could forestall or prevent the need to add drugs and costs to a patient's regimen. |
American Family Physician
September 15, 2006 |
Type 1 Diabetes: What You Should Know A patient guide: What is type 1 diabetes?... What should I do if I have type 1 diabetes?... How do I control my blood sugar level?... What if my blood sugar level gets too low or too high?... etc. |
Managed Care
December 2003
Thomas Morrow |
Can Amylin Analogue Lead To Better Diabetes Control? Maintaining tight glucose control is difficult to accomplish, but adding amylin to the mix may be the answer. |
The Motley Fool
September 19, 2006
Brian Lawler |
A Long Wait for MannKind The company's inhaled insulin might not reach the market for several years, if it does, but it's a big market. Investors, take note. |
